FDA Special Protocol Assessment

Results: 85



#Item
41Clinical research / FDA Special Protocol Assessment / Center for Biologics Evaluation and Research / Dendreon / Cancer vaccine / FDA Fast Track Development Program / Food and Drug Administration / Medicine / Health

Date: June 26, 2007 From: To: Lori Tull, Regulatory Management Staff, OCTGT, HFM – 705 The file, Dendreon STN[removed]

Add to Reading List

Source URL: www.fda.gov

Language: English
42Health / Pharmaceutical sciences / Prescription Drug User Fee Act / FDA Special Protocol Assessment / New Drug Application / Investigational New Drug / Center for Biologics Evaluation and Research / Center for Drug Evaluation and Research / Federal Food /  Drug /  and Cosmetic Act / Food and Drug Administration / Pharmaceuticals policy / Medicine

Microsoft Word - Workload Adjustment Final Report for Changes in Review Activities-FINAL[removed]doc

Add to Reading List

Source URL: www.fda.gov

Language: English
43Clinical research / Prescription Drug User Fee Act / Center for Biologics Evaluation and Research / FDA Special Protocol Assessment / Center for Drug Evaluation and Research / Dermatologic and Ophthalmic Drugs Advisory Committee / Oncology Drug Advisory Committee / Food and Drug Administration / Medicine / Health

Guidance for Industry: Independent Consultants for Biotechnology Clinical Protocols

Add to Reading List

Source URL: www.fda.gov

Language: English
44Pharmaceutical sciences / Pharmacology / Prescription Drug User Fee Act / Orphan drug / Center for Drug Evaluation and Research / FDA Special Protocol Assessment / Food and Drug Administration / Pharmaceuticals policy / Health

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
45Clinical research / Pharmaceuticals policy / Pharmaceutical industry / Prescription Drug User Fee Act / FDA Fast Track Development Program / Drug development / Biosimilar / FDA Special Protocol Assessment / New Drug Application / Food and Drug Administration / Pharmaceutical sciences / Pharmacology

Meetings with FDA F DA Judit Milstein Chief Project Management Staff Division of Transplant and Ophthalmology

Add to Reading List

Source URL: www.fda.gov

Language: English
46Clinical research / Pharmaceuticals policy / Pharmaceutical industry / Prescription Drug User Fee Act / FDA Fast Track Development Program / Biosimilar / Drug development / FDA Special Protocol Assessment / Food and Drug Administration / Pharmaceutical sciences / Pharmacology

Meetings with FDA F DA Judit Milstein Chief Project Management Staff Division of Transplant and Ophthalmology Products

Add to Reading List

Source URL: www.fda.gov

Language: English
47Health / Prescription Drug User Fee Act / FDA Special Protocol Assessment / New Drug Application / Center for Drug Evaluation and Research / Investigational New Drug / Center for Biologics Evaluation and Research / Drug discovery / Priority review voucher / Food and Drug Administration / Pharmaceutical sciences / Medicine

Important Aspects of FDA Safety and Innovation Act for Human Drugs and Biologics Patrick Frey Director, Office of Program and Strategic Analysis (OPSA)

Add to Reading List

Source URL: www.fda.gov

Language: English
48Clinical research / FDA Special Protocol Assessment / Prescription Drug User Fee Act / Center for Biologics Evaluation and Research / Clinical trial / New Drug Application / Center for Drug Evaluation and Research / Communications protocol / Regulatory requirement / Food and Drug Administration / Pharmaceutical sciences / Health

Guidance for Industry Special Protocol Assessment U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

Add to Reading List

Source URL: www.fda.gov

Language: English
49Health / Pharmacology / Prescription Drug User Fee Act / Pharmaceutical industry / Food law / Food and Drug Administration Modernization Act / New Drug Application / Drug development / FDA Special Protocol Assessment / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences

FY 2000 PERFORMANCE REPORT TO CONGRESS for the Prescription Drug User Fee

Add to Reading List

Source URL: www.fda.gov

Language: English
50Health / Prescription Drug User Fee Act / New Drug Application / FDA Special Protocol Assessment / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences

FY 2001 PERFORMANCE REPORT TO CONGRESS for the Prescription Drug User Fee

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE